Literature DB >> 1257360

Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain.

B E Leonard.   

Abstract

The acute administration of 4-chloroamphetamine caused a marked reduction in the concentration of serotonin and 5-hydroxyindoleacetic acid and a rise in dopamine in the rat brain. Following the injection of 3H-tyrosine and 3H-tryptophane into rats treated with 4-chloroamphetamine, there was a reduction in brain levels of 3H-dopamine and 3H-serotonin. Although the endogenous concentration of noradrenaline was not affected by 4-chloroamphetamine, there is evidence that its reuptake into neurones was reduced and its release increased by the drug. Following the administration of 4-chloroamphetamine for 10 days, the concentration of 5-hydroxyindoleacetic acid was reduced; no other changes in amine metabolism were apparent. From this investigation, and those of others, it appears that following acute administration, 4-chloroamphetamine has a neurochemical profile which has a similarity to that of many tricyclic antidepressants. However, there is a marked discrepancy between the acute and chronic effects of 4-CA on brain amine metabolism. Such findings are difficult to reconcile with the widely accepted theory that antidepressant drugs counteract the symptoms of depression by increasing the concentration of noradrenaline and/or serotonin at receptor sites within the brain.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1257360     DOI: 10.1007/BF00421543

Source DB:  PubMed          Journal:  Psychopharmacologia


  37 in total

1.  CHLORINATED ARYLALKYLAMINES AFFECTING THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE.

Authors:  A PLETSCHER; G BARTHOLINI; H BRUDERER; W P BURKARD; K F GEY
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

2.  THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

3.  EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.

Authors:  K E MOORE; E W LARIVIERE
Journal:  Biochem Pharmacol       Date:  1963-11       Impact factor: 5.858

4.  LOWERING OF BRAIN SEROTONIN LEVEL BY CHLORAMPHETAMINES.

Authors:  R W FULLER; C W HINES; J MILLS
Journal:  Biochem Pharmacol       Date:  1965-04       Impact factor: 5.858

5.  Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan.

Authors:  A COPPEN; D M SHAW; J P FARRELL
Journal:  Lancet       Date:  1963-01-12       Impact factor: 79.321

6.  The uptake of tyrosine by rat brain in vitro.

Authors:  G GUROFF; W KING; S UNDENFRIEND
Journal:  J Biol Chem       Date:  1961-06       Impact factor: 5.157

7.  A fluorometric procedure for the measurement of tryptamine in tissues.

Authors:  S M HESS; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

8.  The effects of some tryptamine derivatives on brain monoamines and their precursor amino acids.

Authors:  B E Leonard; S A Shallice
Journal:  Neuropharmacology       Date:  1972-05       Impact factor: 5.250

9.  Comparative effects of p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid.

Authors:  F P Miller; R H Cox; W R Snodgrass; R P Maickel
Journal:  Biochem Pharmacol       Date:  1970-02       Impact factor: 5.858

10.  Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.

Authors:  I P Lapin; G F Oxenkrug
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

View more
  3 in total

1.  Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Authors:  P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

2.  Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Authors:  C W Callaway; M P Johnson; L H Gold; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.

Authors:  G Curzon; J C Fernando; A J Lees
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.